These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37057282)

  • 1. High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma.
    Zhang Y; Li J; Yin X
    J Cancer; 2023; 14(4):646-656. PubMed ID: 37057282
    [No Abstract]   [Full Text] [Related]  

  • 2. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma.
    Li P; Chen F; Yao C; Zhu K; Zhang B; Zheng Z
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
    Mou Y; Zhang L; Liu Z; Song X
    BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.
    Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N6-Methylandenosine-Related Gene
    Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
    Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration].
    Liu Q; Zhang J; Zhang F; Zhang W; Gong L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
    Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
    Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment.
    Zhu H; Hu X; Gu L; Jian Z; Li L; Hu S; Qiu S; Xiong X
    Front Genet; 2021; 12():759953. PubMed ID: 34721547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of POFUT1 as a prognostic predictor in low-grade gliomas: Immune microenvironment insights from a pan-cancer analysis.
    Yu F; Lou S; He H; Zhou Y
    Heliyon; 2024 Mar; 10(5):e27004. PubMed ID: 38463813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
    Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
    Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
    Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased SPTBN2 expression regulated by the ceRNA network is associated with poor prognosis and immune infiltration in low‑grade glioma.
    Chen GR; Zhang YB; Zheng SF; Xu YW; Lin P; Shang-Guan HC; Lin YX; Kang DZ; Yao PS
    Exp Ther Med; 2023 Jun; 25(6):253. PubMed ID: 37153896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.
    Tan Z; Zhang Z; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Mei Y; Shen XL
    Front Neurol; 2022; 13():964590. PubMed ID: 36388191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.